[Form 4] Minerva Neurosciences, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Minerva Neurosciences Chief Business Officer and General Counsel James Joseph O'Connor received a grant of 350,800 employee stock options for common stock. The options have an exercise price of $6.97 per share and are held directly.

The option award vests 25% on April 21, 2027, with the remaining shares vesting in equal quarterly installments over the following three years, and expires on April 20, 2036. This is a compensation-related grant, not an open-market share purchase or sale, and leaves him holding 350,800 options after the transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider O'Connor James Joseph

Role Chief Business Officer and GC

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	350,800	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 350,800 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 350,800 options Exercise price: $6.97 per share Post-transaction holdings: 350,800 options +3 more

6 metrics

Options granted 350,800 options Employee stock option award on April 21, 2026

Exercise price $6.97 per share Conversion or exercise price of option grant

Post-transaction holdings 350,800 options Total options held after the grant

Vesting start April 21, 2027 25% of the options vest on this date

Vesting remainder Quarterly over 3 years Remaining 75% vests in equal quarterly installments

Expiration date April 20, 2036 Option award expiration

Key Terms

Employee Stock Option (right to buy), conversion or exercise price, expiration date, underlying security, +1 more

5 terms

Employee Stock Option (right to buy) financial

"security_title: Employee Stock Option (right to buy)"

conversion or exercise price financial

"conversion_or_exercise_price: 6.9700"

expiration date financial

"expiration_date: 2036-04-20T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

underlying security financial

"underlying_security_title: Common Stock"

vests 25% on April 21, 2027 financial

"The option vests 25% on April 21, 2027 and then quarterly"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Connor James Joseph

(Last) (First) (Middle)

C/O MINERVA NEUROSCIENCES, INC.

1500 DISTRICT AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Minerva Neurosciences, Inc. [ NERV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Business Officer and GC

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$6.97	04/21/2026		A		350,800		(1)	04/20/2036	Common Stock	350,800	$0	350,800	D

Explanation of Responses:

1. The option vests 25% on April 21, 2027 and then in equal quarterly installments over 3 years thereafter.

	/s/ Fred Ahlholm, Attorney-in-Fact	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)